Al-Qaisi R, Al-Gebori A, Alosami M
Indian J Clin Biochem. 2024; 39(3):401-407.
PMID: 39005859
PMC: 11239623.
DOI: 10.1007/s12291-023-01124-5.
Lee B
BMB Rep. 2024; 57(8):352-362.
PMID: 38919014
PMC: 11362137.
Palani H, Ganesan S, Balasundaram N, Venkatraman A, Korula A, Abraham A
Sci Rep. 2024; 14(1):8404.
PMID: 38600158
PMC: 11006665.
DOI: 10.1038/s41598-024-58860-8.
Donsante S, Pievani A, Palmisano B, Finamore M, Fazio G, Corsi A
JCI Insight. 2024; 9(5).
PMID: 38456506
PMC: 10972592.
DOI: 10.1172/jci.insight.173449.
Tomasoni C, Arsuffi C, Donsante S, Corsi A, Riminucci M, Biondi A
Front Immunol. 2023; 14:1320497.
PMID: 38111584
PMC: 10725948.
DOI: 10.3389/fimmu.2023.1320497.
Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy.
Lang Y, Lyu Y, Tan Y, Hu Z
Front Immunol. 2023; 14:1195194.
PMID: 37646021
PMC: 10461088.
DOI: 10.3389/fimmu.2023.1195194.
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies.
Tomasoni C, Pievani A, Rambaldi B, Biondi A, Serafini M
Hemasphere. 2023; 7(6):e896.
PMID: 37234820
PMC: 10208717.
DOI: 10.1097/HS9.0000000000000896.
An humanized model to study homing and sequestration of transmission stages in the bone marrow.
Donsante S, Siciliano G, Ciardo M, Palmisano B, Messina V, de Turris V
Front Cell Infect Microbiol. 2023; 13:1161669.
PMID: 37153157
PMC: 10154621.
DOI: 10.3389/fcimb.2023.1161669.
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
Chen Y, Li J, Xu L, Gaman M, Zou Z
Cell Death Discov. 2022; 8(1):397.
PMID: 36163119
PMC: 9513079.
DOI: 10.1038/s41420-022-01193-0.
Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis.
Dello Spedale Venti M, Palmisano B, Donsante S, Farinacci G, Adotti F, Coletta I
Front Endocrinol (Lausanne). 2022; 13:882379.
PMID: 35757418
PMC: 9215173.
DOI: 10.3389/fendo.2022.882379.
Reduced Osteogenic Differentiation Potential in Acute Myeloid Leukaemia Patients Correlates with Decreased Expression in Mesenchymal Stromal Cells.
Azevedo P, Dias R, Nogueira L, Maradei S, Bigni R, Aragao J
Int J Stem Cells. 2021; 15(2):227-232.
PMID: 34966001
PMC: 9148835.
DOI: 10.15283/ijsc21138.
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies.
Mancini S, Balabanian K, Corre I, Gavard J, Lazennec G, Le Bousse-Kerdiles M
Front Immunol. 2021; 12:766275.
PMID: 34858421
PMC: 8631445.
DOI: 10.3389/fimmu.2021.766275.
Mesenchymal Stromal Cells as a Cellular Target in Myeloid Malignancy: Chances and Challenges in the Genome Editing of Stromal Alterations.
Banjanin B, Schneider R
Front Genome Ed. 2021; 2:618308.
PMID: 34713241
PMC: 8525402.
DOI: 10.3389/fgeed.2020.618308.
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches.
Pievani A, Savoldelli R, Poelchen J, Mattioli E, Anselmi G, Girardot A
Front Immunol. 2021; 12:631279.
PMID: 33790904
PMC: 8006008.
DOI: 10.3389/fimmu.2021.631279.
Location First: Targeting Acute Myeloid Leukemia Within Its Niche.
Pievani A, Biondi M, Tomasoni C, Biondi A, Serafini M
J Clin Med. 2020; 9(5).
PMID: 32443460
PMC: 7290711.
DOI: 10.3390/jcm9051513.